Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases October 28, 2020 Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020 October 15, 2020 OpRegen Data Update to Be Featured in Presentation by Christopher D. Riemann, MD at 2020 American Academy of Ophthalmology Meeting October 13, 2020 Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer VIEW PRESS RELEASES Events & Presentations Third Quarter 2020 Financial Results Earnings Call Nov 4, 2020 at 4:30 PM EST Lineage Cell Therapeutics at Proactive ONE2ONE Virtual Investor Forum Oct 14, 2020 at 1:00 PM EDT Lineage Cell Therapeutics at FORCE Wealth Virtual Fireside Chat Sep 23, 2020 at 12:00 PM EDT VIEW EVENTS & PRESENTATIONS
October 28, 2020 Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020
October 15, 2020 OpRegen Data Update to Be Featured in Presentation by Christopher D. Riemann, MD at 2020 American Academy of Ophthalmology Meeting
October 13, 2020 Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer
